Therapeutic polysaccharide-based coatings have recently emerged as versatile strategies to
transform a conventional medical implant into a drug delivery system. However, the …

The majority of anticancer agents currently used derive from natural sources: plants,
frequently the ones employed in traditional medicines, are an abundant source of mono-and …

Liver fibrosis is a global life-threatening disorder with no approved treatment. It leads to
serious hepatic complications when progressive, such as cirrhosis and carcinoma. Luteolin …

Breast cancer remains the leading cause of cancer-associated mortality in women.
Research investigating novel therapeutic approaches is thus crucial, including …

Parkinson's disease (PD) is the second most common progressive neurodegenerative
disorder associated with increased oxidative stress, the underlying vital process contributing …

Pancreatic cancer is an aggressive malignancy that remains a major cause of cancer-
related deaths. Research for innovative anticancer therapeutic options is thus imperative. In …

Oral cancer is one of the leading causes of death worldwide. Oral precancerous lesions
(OPL) are the precursors of oral cancer, with varying degrees of progression …

Lung cancer seriously threatens the health of human beings, with non-small cell lung cancer
(NSCLC) accounting for 80%. Nowadays, the potential position of nano-delivery in treating …

Chronic myeloid leukemia is a life-threatening blood-cancer prevalent among children and
adolescents. Research for innovative therapeutics combine drug-repurposing …

Fisetin (FS) is considered a safer phytomedicine alternative to conventional
chemotherapeutics for breast cancer treatment. Despite its surpassing therapeutic potential …